BRPI0517166A - uso de d-treo-metilfenidato ou um sal do mesmo - Google Patents
uso de d-treo-metilfenidato ou um sal do mesmoInfo
- Publication number
- BRPI0517166A BRPI0517166A BRPI0517166-0A BRPI0517166A BRPI0517166A BR PI0517166 A BRPI0517166 A BR PI0517166A BR PI0517166 A BRPI0517166 A BR PI0517166A BR PI0517166 A BRPI0517166 A BR PI0517166A
- Authority
- BR
- Brazil
- Prior art keywords
- salt
- threo
- methylphenidate
- entromethylphenidate
- salts
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/445—Non condensed piperidines, e.g. piperocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Abstract
USO DE D-TREO METILFENIDATO OU UM SAL DO MESMO. A presente invenção refere-se ao uso de D-treo metilfenidato ou um sal do mesmo, substancialmente livre de ambos do isómero 1-treo e sais do mesmo e do entrometilfenidato e sais do mesmo para tratar uma doença responsiva a uma administração de metilfenidato e/ou um ou mais isómeros do mesmo, dito método compreendendo identificar um paciente sofrendo de uma doença ou distúrbio tendo um histórico familiar ou diagnóstico de tiques convulsivos ou da Síndrome de Tourette e administrar ao referido paciente uma quantidade terapeuticamente efetiva de D-treo-metilfenidato substancialmente livre do isómero 1-treo e de entrometilfenidato.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US63456204P | 2004-12-09 | 2004-12-09 | |
PCT/US2005/044677 WO2006063256A2 (en) | 2004-12-09 | 2005-12-08 | Treatment using d-threo methylphenidate |
Publications (1)
Publication Number | Publication Date |
---|---|
BRPI0517166A true BRPI0517166A (pt) | 2008-09-30 |
Family
ID=36578626
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
BRPI0517166-0A BRPI0517166A (pt) | 2004-12-09 | 2005-12-08 | uso de d-treo-metilfenidato ou um sal do mesmo |
Country Status (13)
Country | Link |
---|---|
US (2) | US20060127421A1 (pt) |
EP (1) | EP1830648A4 (pt) |
JP (1) | JP2008523097A (pt) |
KR (1) | KR20070087643A (pt) |
CN (1) | CN101076248A (pt) |
AR (1) | AR053655A1 (pt) |
AU (1) | AU2005313887B2 (pt) |
BR (1) | BRPI0517166A (pt) |
CA (1) | CA2591247A1 (pt) |
IL (1) | IL183746A0 (pt) |
NZ (1) | NZ555842A (pt) |
WO (1) | WO2006063256A2 (pt) |
ZA (1) | ZA200705560B (pt) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090076079A1 (en) * | 2007-09-15 | 2009-03-19 | Protia, Llc | Deuterium-enriched methylphenidate |
JP5563824B2 (ja) * | 2007-10-24 | 2014-07-30 | サントリーホールディングス株式会社 | ペルオキシソーム増殖剤応答性受容体(ppar)のリガンド剤 |
KR101921012B1 (ko) * | 2009-10-30 | 2018-11-21 | 교와 메덱스 가부시키가이샤 | 검체 중의 측정 대상 성분의 측정 방법 및 측정용 키트 |
CA2951072A1 (en) * | 2014-06-06 | 2015-12-10 | Rhodes Pharmaceuticals, L.P. | Methods for treating attention deficit hyperactivity disorder with methylphenidate |
Family Cites Families (72)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2507631A (en) * | 1944-01-19 | 1950-05-16 | Ciba Pharm Prod Inc | Pyridine and piperidine compounds and process of making same |
US2957880A (en) * | 1953-12-23 | 1960-10-25 | Ciba Pharm Prod Inc | Process for the conversion of stereoisomers |
US2838519A (en) * | 1953-12-23 | 1958-06-10 | Ciba Pharm Prod Inc | Process for the conversion of stereoisomers |
US4137300A (en) * | 1976-08-20 | 1979-01-30 | Ciba-Geigy Corporation | Sustained action dosage forms |
US4410700A (en) * | 1980-07-03 | 1983-10-18 | The United States Of America As Represented By The Department Of Health And Human Services | Preparation of chiral 1-benzyl-1,2,3,4-tetrahydroisoquinolines by optical resolution |
GB2112730B (en) * | 1981-09-30 | 1985-12-18 | Nat Res Dev | Encapsulated particles |
US4794001A (en) * | 1986-03-04 | 1988-12-27 | American Home Products Corporation | Formulations providing three distinct releases |
US4904476A (en) * | 1986-03-04 | 1990-02-27 | American Home Products Corporation | Formulations providing three distinct releases |
US4986987A (en) * | 1986-05-09 | 1991-01-22 | Alza Corporation | Pulsed drug delivery |
US5114946A (en) * | 1987-06-12 | 1992-05-19 | American Cyanamid Company | Transdermal delivery of pharmaceuticals |
US4992445A (en) * | 1987-06-12 | 1991-02-12 | American Cyanamid Co. | Transdermal delivery of pharmaceuticals |
US5236689A (en) * | 1987-06-25 | 1993-08-17 | Alza Corporation | Multi-unit delivery system |
US5391381A (en) * | 1987-06-25 | 1995-02-21 | Alza Corporation | Dispenser capable of delivering plurality of drug units |
US5283193A (en) * | 1988-06-27 | 1994-02-01 | Asahi Kasei Kogyo K.K. | Process for producing optically active α-substituted organic acid and microorganism and enzyme used therefor |
SE509029C2 (sv) * | 1988-08-16 | 1998-11-30 | Ss Pharmaceutical Co | Långtidsverkande diklofenak-natriumpreparat |
US5202128A (en) * | 1989-01-06 | 1993-04-13 | F. H. Faulding & Co. Limited | Sustained release pharmaceutical composition |
US5133974A (en) * | 1989-05-05 | 1992-07-28 | Kv Pharmaceutical Company | Extended release pharmaceutical formulations |
US5217718A (en) * | 1989-08-18 | 1993-06-08 | Cygnus Therapeutic Systems | Method and device for administering dexmedetomidine transdermally |
US5284769A (en) * | 1989-10-16 | 1994-02-08 | Chiros Ltd. | Process for preparing a single enantiomer of a lactam using lactamase |
US5362755A (en) * | 1990-01-05 | 1994-11-08 | Sepracor, Inc. | Method for treating asthma using optically pure (R)-albuterol |
US5229131A (en) * | 1990-02-05 | 1993-07-20 | University Of Michigan | Pulsatile drug delivery system |
US5158777A (en) * | 1990-02-16 | 1992-10-27 | E. R. Squibb & Sons, Inc. | Captopril formulation providing increased duration of activity |
JP2558396B2 (ja) * | 1990-06-28 | 1996-11-27 | 田辺製薬株式会社 | 放出制御型製剤 |
US5104899A (en) * | 1990-08-13 | 1992-04-14 | Sepracor, Inc. | Methods and compositions for treating depression using optically pure fluoxetine |
US5156850A (en) * | 1990-08-31 | 1992-10-20 | Alza Corporation | Dosage form for time-varying patterns of drug delivery |
US5232705A (en) * | 1990-08-31 | 1993-08-03 | Alza Corporation | Dosage form for time-varying patterns of drug delivery |
US5160744A (en) * | 1991-06-27 | 1992-11-03 | Alza Corporation | Verapmil therapy |
US5326570A (en) * | 1991-07-23 | 1994-07-05 | Pharmavene, Inc. | Advanced drug delivery system and method of treating psychiatric, neurological and other disorders with carbamazepine |
DE69229881T2 (de) * | 1991-10-04 | 1999-12-09 | Yoshitomi Pharmaceutical | Tablette mit verzögerter freisetzung |
DE69222006T2 (de) * | 1991-10-30 | 1998-01-22 | Glaxo Group Ltd | Mehrschichtzusammensetzungen enthaltend Histamin- oder Serotonin- Antagonisten |
US5478577A (en) * | 1993-11-23 | 1995-12-26 | Euroceltique, S.A. | Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level |
US5580578A (en) * | 1992-01-27 | 1996-12-03 | Euro-Celtique, S.A. | Controlled release formulations coated with aqueous dispersions of acrylic polymers |
US5223265A (en) * | 1992-01-10 | 1993-06-29 | Alza Corporation | Osmotic device with delayed activation of drug delivery |
US5308348A (en) * | 1992-02-18 | 1994-05-03 | Alza Corporation | Delivery devices with pulsatile effect |
US5331000A (en) * | 1992-03-09 | 1994-07-19 | Sepracor Inc. | Antipyretic and analgesic methods and compositions containing optically pure R(-) ketoprofen |
US5424950A (en) * | 1992-06-02 | 1995-06-13 | Honeywell Inc. | Vehicle control surface position feedback compensator for reducing vehicle oscillation |
US5299121A (en) * | 1992-06-04 | 1994-03-29 | Medscreen, Inc. | Non-prescription drug medication screening system |
US5512293A (en) * | 1992-07-23 | 1996-04-30 | Alza Corporation | Oral sustained release drug delivery device |
DE69334145T2 (de) * | 1992-08-03 | 2008-01-24 | Sepracor Inc., Marlborough | Terfenadincarboxylat und die Behandlung von Hautreizung |
US5376384A (en) * | 1992-12-23 | 1994-12-27 | Kinaform Technology, Inc. | Delayed, sustained-release pharmaceutical preparation |
JP3091618B2 (ja) * | 1993-01-29 | 2000-09-25 | 四郎 小林 | 開環重合法および開環重合用酵素触媒 |
DE9303805U1 (pt) * | 1993-03-15 | 1993-06-09 | Blumenkron, Jorge Lopez, Puebla, Mx | |
JP2916978B2 (ja) * | 1993-08-25 | 1999-07-05 | エスエス製薬株式会社 | 放出開始制御型製剤 |
US5500227A (en) * | 1993-11-23 | 1996-03-19 | Euro-Celtique, S.A. | Immediate release tablet cores of insoluble drugs having sustained-release coating |
US5567441A (en) * | 1995-03-24 | 1996-10-22 | Andrx Pharmaceuticals Inc. | Diltiazem controlled release formulation |
GB9514451D0 (en) * | 1995-07-14 | 1995-09-13 | Chiroscience Ltd | Sustained-release formulation |
AU708873B2 (en) * | 1995-07-14 | 1999-08-12 | Medeva Europe Limited | Composition comprising d-threo-methylphenidate and another drug |
US6355656B1 (en) * | 1995-12-04 | 2002-03-12 | Celgene Corporation | Phenidate drug formulations having diminished abuse potential |
US5922736A (en) * | 1995-12-04 | 1999-07-13 | Celegene Corporation | Chronic, bolus administration of D-threo methylphenidate |
US5908850A (en) * | 1995-12-04 | 1999-06-01 | Celgene Corporation | Method of treating attention deficit disorders with d-threo methylphenidate |
US5837284A (en) * | 1995-12-04 | 1998-11-17 | Mehta; Atul M. | Delivery of multiple doses of medications |
US6486177B2 (en) * | 1995-12-04 | 2002-11-26 | Celgene Corporation | Methods for treatment of cognitive and menopausal disorders with D-threo methylphenidate |
US5733756A (en) * | 1996-01-05 | 1998-03-31 | Celgene Corporation | Lactams and processes for stereoselective enrichment of lactams, amides, and esters |
US6242464B1 (en) * | 1996-01-22 | 2001-06-05 | Chiroscience Limited | Single isomer methylphenidate and resolution process |
PT879228E (pt) * | 1996-02-02 | 2003-01-31 | Medeva Europ Ltd | Processo para a preparacao de d-treo-(r,r)-metilfenidato e reciclagem de enantiomeros indesejaveis por epimerizacao |
GB9604943D0 (en) * | 1996-03-08 | 1996-05-08 | Chiroscience Ltd | Resolution |
GB9606417D0 (en) * | 1996-03-27 | 1996-06-05 | Chiroscience Ltd | Asymmetric cyclisation |
GB9700912D0 (en) * | 1997-01-17 | 1997-03-05 | Chiroscience Ltd | Resolution |
US5965734A (en) * | 1997-01-31 | 1999-10-12 | Celgene Corporation | Processes and intermediates for preparing 2-substituted piperidine stereoisomers |
US5936091A (en) * | 1997-05-22 | 1999-08-10 | Celgene Corporation | Processes and intermediates for resolving piperidyl acetamide stereoisomers |
US6962997B1 (en) * | 1997-05-22 | 2005-11-08 | Celgene Corporation | Process and intermediates for resolving piperidyl acetamide steroisomers |
DK1126826T6 (en) * | 1998-11-02 | 2019-06-24 | Alkermes Pharma Ireland Ltd | Multiparticulate modified release of methylphenidate |
US6395752B1 (en) * | 1999-03-04 | 2002-05-28 | Pharmaquest Limited | Method of treating depression using 1-threo-methylphenidate |
US6127385A (en) * | 1999-03-04 | 2000-10-03 | Pharmaquest Limited | Method of treating depression using l-threo-methylphenidate |
US20030170181A1 (en) * | 1999-04-06 | 2003-09-11 | Midha Kamal K. | Method for preventing abuse of methylphenidate |
AU4221300A (en) * | 1999-04-06 | 2000-10-23 | Kamal K. Midha | Pharmaceutical dosage form for pulsatile delivery of (d-threo)-methylphenidate and a second cns stimulant |
US6221883B1 (en) * | 2000-04-12 | 2001-04-24 | Ross Baldessarini | Method of dopamine inhibition using l-threo-methylphenidate |
US20020132793A1 (en) * | 2000-08-28 | 2002-09-19 | Mel Epstein | Use of methylphenidate compounds to enhance memory |
US20020103162A1 (en) * | 2000-08-28 | 2002-08-01 | Mel Epstein | Use of threo-methylphenidate compounds to enhance memory |
US6344215B1 (en) * | 2000-10-27 | 2002-02-05 | Eurand America, Inc. | Methylphenidate modified release formulations |
US6359139B1 (en) * | 2000-11-07 | 2002-03-19 | Celgene Corporation | Methods for production of piperidyl acetamide stereoisomers |
WO2004026258A2 (en) * | 2002-09-19 | 2004-04-01 | University Of Utah Research Foundation | Modulating vesicular monoamine transporter trafficking and function: a novel approach for the treatment of parkinson’s disease |
-
2005
- 2005-12-08 US US11/298,093 patent/US20060127421A1/en not_active Abandoned
- 2005-12-08 JP JP2007545674A patent/JP2008523097A/ja active Pending
- 2005-12-08 EP EP05853561A patent/EP1830648A4/en not_active Withdrawn
- 2005-12-08 KR KR1020077015592A patent/KR20070087643A/ko not_active Application Discontinuation
- 2005-12-08 NZ NZ555842A patent/NZ555842A/en not_active IP Right Cessation
- 2005-12-08 CA CA002591247A patent/CA2591247A1/en not_active Abandoned
- 2005-12-08 BR BRPI0517166-0A patent/BRPI0517166A/pt not_active IP Right Cessation
- 2005-12-08 AU AU2005313887A patent/AU2005313887B2/en not_active Ceased
- 2005-12-08 WO PCT/US2005/044677 patent/WO2006063256A2/en active Application Filing
- 2005-12-08 CN CNA2005800425053A patent/CN101076248A/zh active Pending
- 2005-12-09 AR ARP050105159A patent/AR053655A1/es unknown
-
2007
- 2007-06-07 IL IL183746A patent/IL183746A0/en unknown
- 2007-07-06 ZA ZA200705560A patent/ZA200705560B/xx unknown
-
2011
- 2011-01-12 US US13/005,068 patent/US20110118310A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
CA2591247A1 (en) | 2006-06-15 |
US20060127421A1 (en) | 2006-06-15 |
AR053655A1 (es) | 2007-05-16 |
US20110118310A1 (en) | 2011-05-19 |
WO2006063256A3 (en) | 2007-03-29 |
AU2005313887A1 (en) | 2006-06-15 |
ZA200705560B (en) | 2008-11-26 |
CN101076248A (zh) | 2007-11-21 |
NZ555842A (en) | 2010-10-29 |
EP1830648A2 (en) | 2007-09-12 |
IL183746A0 (en) | 2007-10-31 |
AU2005313887B2 (en) | 2011-10-27 |
JP2008523097A (ja) | 2008-07-03 |
WO2006063256A2 (en) | 2006-06-15 |
KR20070087643A (ko) | 2007-08-28 |
EP1830648A4 (en) | 2008-03-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
BR0310099A (pt) | método para tratar dislipidemia ou uma doença associada com a dislipidemia | |
BRPI0408784A (pt) | método para usar um composto | |
AR109170A2 (es) | Esfingomielinasa ácida para uso en la prevención o el tratamiento de la enfermedad de niemann-pick a o b en un paciente | |
BRPI0512213A (pt) | método para tratamento, prevenção ou melhora de uma doença ou distúrbio; composição farmacêutica; processo para a preparação de um composto; e uso de um composto | |
BRPI0406883A (pt) | Composto, composição farmacêutica, método de tratar um distúrbio, e, uso de um composto | |
BRPI0512220A (pt) | método para tratamento, prevenção ou melhora de uma doença ou distúrbio; composição farmacêutica; processo para a preparação de um composto; e uso de um composto | |
BRPI0519195A2 (pt) | composiÇço de cuidado oral, e, mÉtodo para prevenir ou tratar cÁrie dental em um indivÍduo humano ou animal | |
NO20074999L (no) | Metode og preparat for behandling av perifere vaskulaere sykdommer | |
ATE470151T1 (de) | Diagnose, behandlung und prävention von gefässerkrankungen mittels il-1alpha- autoantikörpern | |
BR0314760A (pt) | Compostos orgânicos | |
EA200700232A1 (ru) | Высокоселективные ингибиторы обратного захвата норэпинефрина и способы их применения | |
BRPI0409924A (pt) | ácidos amino carboxìlicos substituìdos | |
EA200700273A1 (ru) | Способ лечения гиперфосфатемии c использованием гидроксикарбоната лантана | |
BRPI0519656A2 (pt) | terapia de combinaÇço compreendendo telmisartan e hidroclorotiazida | |
EA200800397A1 (ru) | Композиции тизанидина и способы лечения с применением композиций | |
EA200970435A1 (ru) | Лечение общих расстройств развития | |
ATE513562T1 (de) | Nicht-spezifische immunstimulierende mittel | |
BRPI0507657A (pt) | composto ou um sal farmaceuticamente aceitável do mesmo, composição farmacêutica, método para tratar um distúrbio, e, uso de um composto ou um sal farmaceuticamente aceitável do mesmo | |
NO20064964L (no) | Behandling av svekket respiratorisk funksjon | |
CY1106775T1 (el) | Φαρμακευτικος συνδυασμος για την προληψη ή θεραπεια καρδιαγγειακων, καρδιοπνευμονικων πνευμονικων ή νεφρικων παθησεων | |
WO2006029142A3 (en) | Methods and systems for treating asthma and other respiratory diseases | |
WO2010020585A1 (en) | Serotonin reuptake inhibitors for the treatment of rett syndrome | |
BRPI0517166A (pt) | uso de d-treo-metilfenidato ou um sal do mesmo | |
BRPI0510137A (pt) | medicamentos contendo n-sulfamoil-n'-arilpiperazinas para a profilaxia ou tratamento da obesidade e condições relacionadas | |
BRPI0413404A (pt) | composições farmacêuticas, métodos de tratamento ou prevenção de disfunções cardìacas, métodos de aumento da função cardìaca e método de identificação de inibidor de mif |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
B08F | Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette] |
Free format text: REFERENTE A 10A ANUIDADE. |
|
B08K | Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette] |
Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2343 DE 01-12-2015 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013. |